These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25840791)

  • 1. Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines.
    Zhang Y; Zhang X; Huang J; Dong Q
    Med Oncol; 2015 May; 32(5):157. PubMed ID: 25840791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
    Lin Y; Higashisaka K; Shintani T; Maki A; Hanamuro S; Haga Y; Maeda S; Tsujino H; Nagano K; Fujio Y; Tsutsumi Y
    Sci Rep; 2020 Mar; 10(1):4748. PubMed ID: 32179851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J; Wu S; Wu H; Li L; Guo T
    Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
    Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
    Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
    He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
    Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer.
    Li Y; Ma C; Shi X; Wen Z; Li D; Sun M; Ding H
    Oncol Rep; 2014 Oct; 32(4):1703-8. PubMed ID: 25070480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.
    Teng Y; Wang X; Wang Y; Ma D
    Biochem Biophys Res Commun; 2010 Feb; 392(3):373-9. PubMed ID: 20074550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WDR74 induces nuclear β-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis.
    Li Y; Chen F; Shen W; Li B; Xiang R; Qu L; Zhang C; Li G; Xie H; Katanaev VL; Jia L
    Cancer Lett; 2020 Feb; 471():103-115. PubMed ID: 31838084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
    Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
    Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
    Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
    Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 16. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
    Shu X; Chen M; Liu SY; Yu L; Sun LX; Sun LC; Ran YL
    Cancer Med; 2023 Feb; 12(4):4510-4520. PubMed ID: 36047666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy.
    Spitzner M; Emons G; Schütz KB; Wolff HA; Rieken S; Ghadimi BM; Schneider G; Grade M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Wnt signaling under hypoxia promotes lung cancer progression.
    Hong CF; Chen WY; Wu CW
    Oncol Rep; 2017 Sep; 38(3):1706-1714. PubMed ID: 28713928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.